Galapagos (GLPG) Competitors

Galapagos (NASDAQ:GLPG) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, risk, earnings, analyst recommendations, valuation, media sentiment, institutional ownership and profitability.

Does the media favor GLPG or ATNFW?

In the previous week, Galapagos' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company	Overall Sentiment
Galapagos	Neutral
180 Life Sciences	Neutral

Is GLPG or ATNFW more profitable?

Company	Net Margins	Return on Equity	Return on Assets
Galapagos	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A

Do analysts rate GLPG or ATNFW?

Galapagos presently has a consensus price target of $25.33, suggesting a potential downside of 18.65%. Given Galapagos' stronger consensus rating and higher probable upside, equities research analysts clearly believe Galapagos is more favorable than 180 Life Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Galapagos	4 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Do institutionals and insiders have more ownership in GLPG or ATNFW?

32.5% of Galapagos shares are held by institutional investors. 2.9% of Galapagos shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Which has higher earnings & valuation, GLPG or ATNFW?

Galapagos has higher revenue and earnings than 180 Life Sciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Galapagos	$298.31M	N/A	$80.16M	N/A	N/A
180 Life Sciences	N/A	N/A	N/A	N/A	N/A

Summary

Galapagos beats 180 Life Sciences on 5 of the 5 factors compared between the two stocks.